Parnax Lab

Parnax Lab EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Parnax Lab (506128.BO) as of Nov 20, 2026 is 6.55. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 14.04 — a change of -53.32% (lower).

EV/OCF

6.55

YoY

-53.32%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Parnax Lab is 2025 6.55 . EV/OCF (Enterprise Value to Operating Cash Flow) of Parnax Lab was 2024 14.04 . It decreases by -53.32% lower compared to the previous year.

The Parnax Lab EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
13.80 INR
Jan 1, 2019
21.12 INR
Jan 1, 2020
22.03 INR
Jan 1, 2021
31.76 INR
Jan 1, 2022
24.11 INR
Jan 1, 2023
9.38 INR
Jan 1, 2024
14.04 INR
Jan 1, 2025
6.55 INR
The Parnax Lab EV/OCF history
YEAREV/OCFYoY
6.55-53.32%
14.04+49.65%
9.38-61.09%
24.11-24.09%
31.76+44.16%
22.03+4.31%
21.12+53.07%
13.80-22.18%
17.73-70.13%
59.35-107.12%
-833.74-37.62%
-1,336.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Parnax Lab is 6.55 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Parnax Lab changed from 14.04 to 6.55, representing a -53.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab